Lov-D acyltransferase mediated acylation
US-10428360-B2 · Oct 1, 2019 · US
US12060592B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12060592-B2 |
| Application number | US-202017089498-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 4, 2020 |
| Priority date | Sep 30, 2009 |
| Publication date | Aug 13, 2024 |
| Grant date | Aug 13, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for the improved acylation of chemical substrates using LovD acyltransferases, thioesters having acyl groups, and (i) thiol scavengers and/or (ii) precipitating agents are presented. An improved method for the production of simvastatin using (i) activated charcoal as a thiol scavenger and/or (ii) ammonium hydroxide as a precipitating agent is also presented.
Opening claim text (preview).
What is claimed is: 1. A non-naturally occurring variant LovD polypeptide having at least two-fold greater acyltransferase activity than the wild-type Aspergillus terreus acyltransferase of SEQ ID NO: 2, which comprises a variant amino acid sequence of SEQ ID NO: 2 that includes a mutation at position 157 and from 1 to 30 additional mutations, as compared to SEQ ID NO: 2. 2. The non-naturally occurring variant LovD polypeptide of claim 1 , which has at least 10-fold greater acyltransferase activity than the wild-type A. terreus acyltransferase of SEQ ID NO: 2. 3. The non-naturally occurring variant LovD polypeptide of claim 1 , that includes the following additional mutations: A123P, N191S/G, A247S and L361M. 4. The non-naturally occurring variant LovD polypeptide of claim 3 , further comprising one or more additional mutations selected from: A9V, K26E, L192I, R250K, G275S, Q297E/G, and A383V. 5. The non-naturally occurring variant LovD polypeptide of claim 4 , wherein the one or more additional mutations are selected from: A9V, K26E, and G275S.
Genes encoding for enzymes or proenzymes · CPC title
transferring groups other than amino-acyl groups (2.3.1) · CPC title
using catalysts, e.g. selective catalysts · CPC title
Acyltransferases (2.3) · CPC title
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.